Impact Factor
4.06
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.64
2,906 total citations
h5-index
51
h5 depth signal
Cited share
78.5%
518 of 660
Total citations
2,906
Citation footprint
Metric signal
5.10
External metric anchor
Self-citation
2.1%
60 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
796
United States
478
France
332
Italy
238
Spain
236
Citing Fields of Research
Antibiotic & Antibacterial Agents
2,278
Bacteriology
945
Virology
206
Fungal Pathogenesis
180
HIV
121
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
11,981
Articles tracked across the journal lifetime
Indexed publication set
660
518 cited publications
Last 12 months
367
30.6 publications/month
Open access share
30.2%
111 OA publications in the last year
Leading citing country
China
796 citing publications
Leading citing field
Antibiotic & Antibacterial Agents
2,278 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v9n3, Jan. 1997-
v9n3, Jan. 1997-
Active Coverage
Research Focus & Classification
Indexed Subjects
Antibiotic & Antibacterial Agents
Issuing & Sponsoring Bodies
Contributor
International Society of Chemotherapy
Broad Categories
Anti-Infective Agents
Antibiotic & Antibacterial Agents
MeSH Descriptors
Anti-Bacterial Agents
Anti-Infective Agents
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.ijantimicag.2026.108036
Open DOI
Combining minocycline with polymyxin B against Klebsiella pneumoniae in neutropenic murine infection models: one plus one is more than two.
02
03
DOI 10.1016/j.ijantimicag.2026.108037
Open DOI
AI strategies to combat antimicrobial resistance
04
DOI 10.1016/j.ijantimicag.2026.108034
Open DOI
Concentration and penetration of nemonoxacin in bronchopulmonary tissues of patients undergoing pulmonary surgery: an observational PK study
05
DOI 10.1016/j.ijantimicag.2026.108035
Open DOI
Vancomycin Population Pharmacokinetics and Exposure Variability in Children with Multiple Organ Dysfunction Syndrome
06
DOI 10.1016/j.ijantimicag.2026.108015
Open DOI
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page
07
DOI 10.1016/j.ijantimicag.2026.108032
Open DOI
Advancing bacteriophage therapy through encapsulation: An evidence-based scoping review from animal trials
08
DOI 10.1016/j.ijantimicag.2026.108024
Open DOI
Antibacterial dose optimization in patients with febrile neutropenia: Are we targeting the right patients and the right endpoints?
09
DOI 10.1016/j.ijantimicag.2026.108021
Open DOI
Vancomycin treatment outcomes and machine learning-based identification of heterogeneous vancomycin-intermediate Staphylococcus aureus infections
10
Bibliographical & Catalog Notes
Six issues per year.
Print issues ceased with v. 48, no. 6 (2016).
Called also: Vol. 1, no. 1- .
Has supplements.
Also available online.
Issued by: International Society of Chemotherapy.
Vol. 1, no. 1 (JUNE 1991)19980707 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper